A citation-based method for searching scientific literature

Yoo Jin Jung, David Tweedie, Michael T Scerba, Dong Seok Kim, Maria Francesca Palmas, Augusta Pisanu, Anna R Carta, Nigel H Greig. Front Neurosci 2021
Times Cited: 6







List of co-cited articles
43 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro.
Chris Mahony, Lynda Erskine, Jennifer Niven, Nigel H Greig, William Douglas Figg, Neil Vargesson. Proc Natl Acad Sci U S A 2013
44
83

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
A L Moreira, E P Sampaio, A Zmuidzinas, P Frindt, K A Smith, G Kaplan. J Exp Med 1993
906
83

3,6'-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation.
Chih-Tung Lin, Daniela Lecca, Ling-Yu Yang, Weiming Luo, Michael T Scerba, David Tweedie, Pen-Sen Huang, Yoo-Jin Jung, Dong Seok Kim, Chih-Hao Yang,[...]. Elife 2020
17
83

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.
E P Sampaio, E N Sarno, R Galilly, Z A Cohn, G Kaplan. J Exp Med 1991
66

Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.
Jin-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, David Tweedie, Weiming Luo, Chaim G Pick, Szu-Yi Chou, Yu Luo, Barry J Hoffer, Nigel H Greig,[...]. J Neuroinflammation 2016
30
66

Pomalidomide Reduces Ischemic Brain Injury in Rodents.
Yan-Rou Tsai, David Tweedie, Ignacio Navas-Enamorado, Michael T Scerba, Cheng-Fu Chang, Jing-Huei Lai, John Chung-Che Wu, Yen-Hua Chen, Shuo-Jhen Kang, Barry J Hoffer,[...]. Cell Transplant 2019
10
66

SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate.
Mary E Matyskiela, Suzana Couto, Xinde Zheng, Gang Lu, Julia Hui, Katie Stamp, Clifton Drew, Yan Ren, Maria Wang, Aaron Carpenter,[...]. Nat Chem Biol 2018
126
50

Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.
Evangelos Terpos, Nikolaos Kanellias, Dimitrios Christoulas, Efstathios Kastritis, Meletios A Dimopoulos. Onco Targets Ther 2013
20
50

Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.
David Tweedie, Ryan A Ferguson, Kelly Fishman, Kathryn A Frankola, Henriette Van Praag, Harold W Holloway, Weiming Luo, Yazhou Li, Luca Caracciolo, Isabella Russo,[...]. J Neuroinflammation 2012
144
50

Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice.
Renana Baratz, David Tweedie, Jia-Yi Wang, Vardit Rubovitch, Weiming Luo, Barry J Hoffer, Nigel H Greig, Chaim G Pick. J Neuroinflammation 2015
88
50

Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.
Kathryn A Frankola, Nigel H Greig, Weiming Luo, David Tweedie. CNS Neurol Disord Drug Targets 2011
154
50

Reply to D’Amato et al. and Zeldis et al.: Screening of thalidomide derivatives in chicken and zebrafish embryos.
Neil Vargesson, Chris Mahony, Lynda Erskine, Jennifer Niven, Nigel H Greig, William Douglas Figg. Proc Natl Acad Sci U S A 2013
7
50

Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice.
Emma C Fink, Marie McConkey, Dylan N Adams, Saurav D Haldar, James A Kennedy, Andrew A Guirguis, Namrata D Udeshi, D R Mani, Michelle Chen, Brian Liddicoat,[...]. Blood 2018
49
33

Evaluation of the developmental toxicity of lenalidomide in rabbits.
Mildred S Christian, Oscar L Laskin, Valerie Sharper, Alan Hoberman, David I Stirling, Louise Latriano. Birth Defects Res B Dev Reprod Toxicol 2007
28
33

Thalidomide is an inhibitor of angiogenesis.
R J D'Amato, M S Loughnan, E Flynn, J Folkman. Proc Natl Acad Sci U S A 1994
33

Identification of a primary target of thalidomide teratogenicity.
Takumi Ito, Hideki Ando, Takayuki Suzuki, Toshihiko Ogura, Kentaro Hotta, Yoshimasa Imamura, Yuki Yamaguchi, Hiroshi Handa. Science 2010
33

Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.
Jan Krönke, Namrata D Udeshi, Anupama Narla, Peter Grauman, Slater N Hurst, Marie McConkey, Tanya Svinkina, Dirk Heckl, Eamon Comer, Xiaoyu Li,[...]. Science 2014
990
33

Recent advances in the molecular mechanism of thalidomide teratogenicity.
Shaobing Gao, Shichao Wang, Ruihua Fan, Jieying Hu. Biomed Pharmacother 2020
9
33

N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.
Shih Chang Hsueh, Weiming Luo, David Tweedie, Dong Seok Kim, Yu Kyung Kim, Inho Hwang, Jung-Eun Gil, Baek-Soo Han, Yung-Hsiao Chiang, Warren Selman,[...]. ACS Pharmacol Transl Sci 2021
4
50

Neuroinflammation in animal models of traumatic brain injury.
Chong-Chi Chiu, Yi-En Liao, Ling-Yu Yang, Jing-Ya Wang, David Tweedie, Hanuma K Karnati, Nigel H Greig, Jia-Yi Wang. J Neurosci Methods 2016
137
33


The neuropathology of traumatic brain injury.
Ann C Mckee, Daniel H Daneshvar. Handb Clin Neurol 2015
269
33

Inflammatory response in acute traumatic brain injury: a double-edged sword.
Maria Cristina Morganti-Kossmann, Mario Rancan, Philip F Stahel, Thomas Kossmann. Curr Opin Crit Care 2002
461
33

MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
Boris Decourt, Jeffrey Wilson, Aaron Ritter, Christopher Dardis, Frank P DiFilippo, Xiaowei Zhuang, Dietmar Cordes, Garam Lee, Nadia D Fulkerson, Tessa St Rose,[...]. Open Access J Clin Trials 2020
14
33

Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.
Gregory Scott, Henrik Zetterberg, Amy Jolly, James H Cole, Sara De Simoni, Peter O Jenkins, Claire Feeney, David R Owen, Anne Lingford-Hughes, Oliver Howes,[...]. Brain 2018
93
33

Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments.
Yoo Jin Jung, David Tweedie, Michael T Scerba, Nigel H Greig. Front Cell Dev Biol 2019
58
33

Estimating the global incidence of traumatic brain injury.
Michael C Dewan, Abbas Rattani, Saksham Gupta, Ronnie E Baticulon, Ya-Ching Hung, Maria Punchak, Amit Agrawal, Amos O Adeleye, Mark G Shrime, Andrés M Rubiano,[...]. J Neurosurg 2018
759
33

Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity.
Xiaoxiang Zhu, Tony Giordano, Qian-Sheng Yu, Harold W Holloway, Tracy Ann Perry, Debomoy K Lahiri, Arnold Brossi, Nigel H Greig. J Med Chem 2003
59
33

The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications.
Katarzyna Z Kuter, M Angela Cenci, Anna R Carta. Prog Brain Res 2020
11
33



Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue.
Yao Jiang, Jiang Wang, Darlene M Rozewski, Shamalatha Kolli, Chia-Hsien Wu, Ching-Shih Chen, Xiaoxia Yang, Craig C Hofmeister, John C Byrd, Amy J Johnson,[...]. J Pharm Biomed Anal 2014
17
33

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson's Disease.
Maria Antonietta Casu, Ignazia Mocci, Raffaella Isola, Augusta Pisanu, Laura Boi, Giovanna Mulas, Nigel H Greig, Maria Dolores Setzu, Anna R Carta. Front Aging Neurosci 2020
9
33

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma.
A A Chanan-Khan, A Swaika, A Paulus, S K Kumar, J R Mikhael, S V Rajkumar, A Dispenzieri, M Q Lacy. Blood Cancer J 2013
69
33

Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial.
Boris Decourt, Denise Drumm-Gurnee, Jeffrey Wilson, Sandra Jacobson, Christine Belden, Sherye Sirrel, Michael Ahmadi, Holly Shill, Jessica Powell, Aaron Walker,[...]. Curr Alzheimer Res 2017
37
33

Characterizing microglia activation: a spatial statistics approach to maximize information extraction.
Benjamin M Davis, Manual Salinas-Navarro, M Francesca Cordeiro, Lieve Moons, Lies De Groef. Sci Rep 2017
153
33

In search of an anti-inflammatory drug for Alzheimer disease.
Erika Gyengesi, Gerald Münch. Nat Rev Neurol 2020
25
33

The European medicines agency review of pomalidomide in combination with low-dose dexamethasone for the treatment of adult patients with multiple myeloma: summary of the scientific assessment of the committee for medicinal products for human use.
Zahra Hanaizi, Beatriz Flores, Robert Hemmings, Jorge Camarero, Arantxa Sancho-Lopez, Tomas Salmonson, Christian Gisselbrecht, Edward Laane, Francesco Pignatti. Oncologist 2015
19
33

Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study.
Jesse R Fann, Anette Riisgaard Ribe, Henrik Schou Pedersen, Morten Fenger-Grøn, Jakob Christensen, Michael Eriksen Benros, Mogens Vestergaard. Lancet Psychiatry 2018
147
33



Molecular mechanisms of cereblon-based drugs.
Tomoko Asatsuma-Okumura, Takumi Ito, Hiroshi Handa. Pharmacol Ther 2019
33
33

A review of the history, properties, and use of the immunomodulatory compound lenalidomide.
Jerome B Zeldis, Robert Knight, Mohamad Hussein, Rajesh Chopra, George Muller. Ann N Y Acad Sci 2011
50
33

TRRUST: a reference database of human transcriptional regulatory interactions.
Heonjong Han, Hongseok Shim, Donghyun Shin, Jung Eun Shim, Yunhee Ko, Junha Shin, Hanhae Kim, Ara Cho, Eiru Kim, Tak Lee,[...]. Sci Rep 2015
186
16

DCGL v2.0: an R package for unveiling differential regulation from differential co-expression.
Jing Yang, Hui Yu, Bao-Hong Liu, Zhongming Zhao, Lei Liu, Liang-Xiao Ma, Yi-Xue Li, Yuan-Yuan Li. PLoS One 2013
73
16


The effect of thalidomide in chicken embryos.
Trent D Stephens. Birth Defects Res A Clin Mol Teratol 2009
8
16

Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion.
Hugo Vega, Quinten Waisfisz, Miriam Gordillo, Norio Sakai, Itaru Yanagihara, Minoru Yamada, Djoke van Gosliga, Hülya Kayserili, Chengzhe Xu, Keiichi Ozono,[...]. Nat Genet 2005
269
16

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation.
Christina Therapontos, Lynda Erskine, Erin R Gardner, William D Figg, Neil Vargesson. Proc Natl Acad Sci U S A 2009
163
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.